Patent · US Active

Quinoline alkenes as cytoprotective agents

US10800766B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Inventor

Key dates

Filing dateJun 10, 2019
Grant dateOct 13, 2020
Priority date—
Expiry dateJun 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D215/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.